Journal Metrics | Nature Portfolio
The past, present and future of Registered Reports | Nature Human Behaviour
🏆 Nature Medicine | Impact Factor | Indexing | Acceptance rate | Abbreviation - Open access journals
Nature Medicine Impact Factor 2022 - Journal Impact Factor
Nature journals reveal terms of landmark open-access option
npj Genomic Medicine
Single-cell multi-omics analysis of the immune response in COVID-19 | Nature Medicine
About Scientific Reports | Scientific Reports
Nature (journal) - Wikipedia
The next generation of evidence-based medicine | Nature Medicine
A guide to immunotherapy for COVID-19 | Nature Medicine
Nature Medicine
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine
Open access at the Nature Portfolio | Nature Portfolio
![PDF] Acceptance rates of scholarly peer-reviewed journals: A literature survey | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a699f8548afa6103288d0809cf21751bb6512b02/6-Table2-1.png "PDF] Acceptance rates of scholarly peer-reviewed journals: A literature survey | Semantic Scholar")
PDF] Acceptance rates of scholarly peer-reviewed journals: A literature survey | Semantic Scholar
Nature Medicine (@NatureMedicine) / Twitter
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021 | Nature Communications
Open access: The true cost of science publishing | Nature
Scientific Reports
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
AI in health and medicine | Nature Medicine
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma | Nature Medicine
Molecular Medicine | Home
Federated learning for predicting clinical outcomes in patients with COVID-19 | Nature Medicine
